Minimally Invasive Treatment Methods for Pilonidal Disease

Uşak University200 enrolled

Overview

Patients with pilonidal sinus disease will be randomised to two groups (crystallised phenol and platelet rich plasma). Sinus healing time, patient satisfaction, complications and recurrence rates will be compared.

Patients with pilonidal sinus disease will be treated by either crystallised phenol or platelet rich plasma application. Treatment results, healing time, postprocedural complications, patient satisfaction and recurrences will be compared.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

200

Conditions

Pilonidal Sinus

Interventions

crystallised phenolPROCEDURE

crystallised phenol will be applied to sinus cavity

Platelet rich plasmaPROCEDURE

platelet rich plasma will be applied to sinus cavity

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Having pilonidal sinus disease * accepting to be involved in the study Exclusion Criteria: * below the age of 18 * having connective tissue disorders * diabetes mellitus * severe anemia

Locations (1)

Uşak University

Uşak, Turkey (Türkiye)

Outcomes

Primary Outcomes

healing time

Time to complete closure of the sinus cavity.

Time frame: first 1 year of the study

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.